Literature DB >> 7845341

Pregnancy, teratogenesis, and epilepsy.

M S Yerby1.   

Abstract

Women with epilepsy who are of childbearing age need to understand what the risks of pregnancy are. These women have a 33% risk of increased seizures, a twofold increase in risk of hemorrhage, eclampsia, premature labor, and an increased need for cesarean sections. Babies born to women with epilepsy face a higher risk of miscarriage, stillbirth, prematurity, developmental delay, and major malformations. Seizure control should be obtained without clinical toxicity. Monotherapy reduces the risk of adverse outcomes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7845341

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  9 in total

1.  Fetal valproate syndrome: the Irish experience.

Authors:  Hamizah Mohd Yunos; Andrew Green
Journal:  Ir J Med Sci       Date:  2018-02-03       Impact factor: 1.568

Review 2.  Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child.

Authors:  Jennifer Weston; Rebecca Bromley; Cerian F Jackson; Naghme Adab; Jill Clayton-Smith; Janette Greenhalgh; Juliet Hounsome; Andrew J McKay; Catrin Tudur Smith; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2016-11-07

Review 3.  Teratogenic potential of the newer antiepileptic drugs: what is known and how should this influence prescribing?

Authors:  Carmela Palmieri; Raffaele Canger
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

4.  Additional educational needs in children born to mothers with epilepsy.

Authors:  N Adab; A Jacoby; D Smith; D Chadwick
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-01       Impact factor: 10.154

5.  Pregnancy outcome after in utero exposure to valproate : evidence of dose relationship in teratogenic effect.

Authors:  Orna Diav-Citrin; Svetlana Shechtman; Benjamin Bar-Oz; Dana Cantrell; Judy Arnon; Asher Ornoy
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

6.  Malformation rates in children of women with untreated epilepsy: a meta-analysis.

Authors:  Shawn Fried; Eran Kozer; Irena Nulman; Thomas R Einarson; Gideon Koren
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 7.  Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child.

Authors:  Rebecca Bromley; Jennifer Weston; Naghme Adab; Janette Greenhalgh; Anna Sanniti; Andrew J McKay; Catrin Tudur Smith; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2014-10-30

8.  Clinical characteristics and pregnancy outcomes of new onset epilepsy during pregnancy.

Authors:  Wei Li; Nanya Hao; Yingfeng Xiao; Dong Zhou
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

9.  Comparative safety of anti-epileptic drugs among infants and children exposed in utero or during breastfeeding: protocol for a systematic review and network meta-analysis.

Authors:  Andrea C Tricco; Elise Cogo; Veroniki A Angeliki; Charlene Soobiah; Brian Hutton; Brenda R Hemmelgarn; David Moher; Yaron Finkelstein; Sharon E Straus
Journal:  Syst Rev       Date:  2014-06-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.